N-methyl-D-aspartate (NMDA)
Showing 1 - 25 of >10,000
Therapy of Anti-NMDAR Encephalitis at Diagnosis
Active, not recruiting
- Anti-NMDA (N-Methyl D-Aspartate) Receptor Encephalitis
-
Rotterdam, NetherlandsErasmus Medical Center
Sep 4, 2023
Clinical-immunological Features of Anti-NMDAR Encephalitis
Active, not recruiting
- Anti NMDA Receptor Encephalitis
- Description of clinical characteristic
-
Lyon, Bron, FranceHôpital Neurologique Pierre Wertheimer / Groupement Hospitalier
Feb 12, 2023
Anti-NMDAR Encephalitis Trial in Paris (IA session, Rituximab)
Recruiting
- Anti-NMDAR Encephalitis
- IA session
- Rituximab
-
Paris, FranceHôpital Necker Enfants-Malades
Oct 31, 2022
Psycho-social Impact of Anti-NMDAR Encephalitis
Not yet recruiting
- NMDAR Antibody-associated Auto-immune Encephalitis
- standardized and validated surveys
-
Bron, FranceCentre de référence des syndromes neurologiques paranéoplasiques
Jul 13, 2023
Developing Advanced Neuroimaging for Clinical Evaluation of
Recruiting
- Anti-N-Methyl-D-Aspartate Receptor Encephalitis
- Autoimmune Encephalitis
- Not applicable - non-interventional study
-
London, Greater London, United KingdomGuy's and St Thomas' NHS Foundation Trust
Jun 14, 2022
Depression, Alcohol Dependence Trial in West Haven (Ketalar (ketamine))
Completed
- Depression
- Alcohol Dependence
- Ketalar (ketamine)
-
West Haven, ConnecticutVA CT Healthcare Systems
Mar 5, 2020
Paraneoplastic Neurologic Encephalitis and Mature Cystic
Recruiting
- Ovarian Dermoid Cyst
- Blood sample
-
Rishon LeZion, IsraelShamir medical center
Jan 23, 2022
Diagnostic Score for Encephalitis to Assess Risk of Autoimmune
Recruiting
- Autoimmune Encephalitis
- Autoimmune Encephalitis Caused by N-Methyl D-Aspartate Receptor Antibody (Disorder)
- Clinical score of Granillo and al.
-
Lyon, FranceCentre de référence des syndromes neurologiques paranéoplasiques
Jul 12, 2023
Autoimmune Encephalitis With Anti-NMDA Receptor Antibodies
Unknown status
- Autoimmune Encephalitis
- +2 more
- Description and analysis
-
Bron, FranceHospice Civils de Lyon
Apr 6, 2020
Postoperative Pain Trial in Denizli (Magnesium Sulfate, normal saline isotonic solution)
Completed
- Postoperative Pain
- Magnesium Sulfate
- normal saline isotonic solution
-
Denizli, TurkeyPamukkale Univercity Medical School
May 25, 2023
Schizophrenia Trial in Taichung (NMDAE, Placebo Cap)
Not yet recruiting
- Schizophrenia
- NMDAE
- Placebo Cap
-
Taichung, TaiwanDepartment of Psychiatry, China Medical University Hospital
Sep 4, 2023
GWAS in NMDAR Encephalitis
Recruiting
- Autoimmune Encephalitis
- GWAS
-
Lyon, FranceCentre de référence des syndromes neurologiques paranéoplasiques
Feb 4, 2022
Magnesium, Intraoperative Analgesia Trial (Magnesium Sulfate, Propofol)
Not yet recruiting
- Magnesium
- Intraoperative Analgesia
- Magnesium Sulfate
- Propofol
- (no location specified)
Nov 12, 2023
NMDAR Autoimmune Encephalitis, LGI1 Autoimmune Encephalitis Trial in Prague, Praha 5 (Satralizumab, Placebo)
Not yet recruiting
- NMDAR Autoimmune Encephalitis
- LGI1 Autoimmune Encephalitis
- Satralizumab
- Placebo
-
Prague, Czechia
- +1 more
Aug 15, 2022
Breast Cancer Trial in Cairo (Bupivacaine Hydrochloride, Bupivacaine Hydrochloride and dexmedetomedine, Bupivacaine
Recruiting
- Breast Cancer
- Bupivacaine Hydrochloride
- +2 more
-
Cairo, EgyptHanafy
Feb 13, 2023
Drug-resistant Psychiatric Disorders Using Induced Pluripotent
Enrolling by invitation
- Depressive Disorder, Treatment-Resistant
-
Monza, Monza E Brianza, ItalyFondazione IRCCS San Gerardo di Monza
May 24, 2023
Learning and Memory in Healthy Individuals and Those With Psychiatric Illness Trial in Chicago (GLYX-13, Placebo)
Terminated
- Learning and Memory in Healthy Individuals and Those With Psychiatric Illness
- GLYX-13
- Placebo
-
Chicago, IllinoisNorthwestern University
Jan 14, 2022
Episiotomy Wound, Pain, Procedural Trial (Magnesium sulfate)
Not yet recruiting
- Episiotomy Wound
- Pain, Procedural
- Magnesium sulfate
- (no location specified)
Jun 9, 2022
Treatment Resistant Schizophrenia Trial in Bhubaneswar (Dextromethorphan, Placebo)
Not yet recruiting
- Treatment Resistant Schizophrenia
- Dextromethorphan
- Placebo
-
Bhubaneswar, Odisha, IndiaAll India Institute of Medical Sciences (AIIMS)
Jul 15, 2023
Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Philadelphia (Palbociclib, Tazemetostat,
Not yet recruiting
- Recurrent Acute Myeloid Leukemia
- Refractory Acute Myeloid Leukemia
- Palbociclib
- +4 more
-
Philadelphia, PennsylvaniaThomas Jefferson University Hospital
Jan 13, 2023
Healthy Individuals Trial in Leuven (drug, genetic, other)
Withdrawn
- Healthy Individuals
- d-Cycloserine
- +3 more
-
Leuven, BelgiumCatholic University Leuven, Departement of Radiology
Jan 27, 2023
Scoliosis Correction, Postoperative Analgesia, Esketamine Trial in Beijing (Esketamine)
Not yet recruiting
- Scoliosis Correction
- +4 more
-
Beijing, Beijing, ChinaBeijing University First Hospital
Oct 17, 2023
Scoliosis Correction, Postoperative Analgesia, Esketamine Trial in Beijing (Esketamine, Dexmedetomidine, Sufentanil)
Active, not recruiting
- Scoliosis Correction
- +4 more
- Esketamine
- +2 more
-
Beijing, Beijing, ChinaPeking University First Hospital
Feb 7, 2023
Preemptive Analgesia, Dexmedetomidine, Ketamine Trial in Kafr Ash Shaykh (Dexmedetomidine, Ketamine, Magnesium sulphate)
Not yet recruiting
- Preemptive Analgesia
- +5 more
- Dexmedetomidine
- +2 more
-
Kafr Ash Shaykh, Karelsheikh, EgyptKarelsheikh University Hospital
Apr 19, 2023
Liver Failure, Liver Transplant; Complications, Post Operative Pain Trial in Malatya (Low dose ketamine infusion, 0.9% NaCl
Recruiting
- Liver Failure
- +2 more
- Low dose ketamine infusion
- 0.9% NaCl infusion
-
Malatya, TurkeyInonu university
Jul 1, 2022